8 completed, 1 withdrawn. 9 Phase 1.
By phase and status
Follow SRT2104: new trials by email Literature Review of SRT2104 trials Research Report on SRT2104
Trials (filtered) newest first · largest first
All 9 trials
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
A Phase 1b Study to Assess the Safety and Anti-inflammatory Effects of Two Different Doses of SRT2104 in Patients With Ulcerative Colitis SRT2104 - Colitis, Ulcerative | Phase 1 | Completed | 17 | 2012-02-13 | 2017-06-01 |
A Clinical Study to Assess the Effects of SRT2104 Upon Immobilization-Induced Skeletal Muscle Atrophy in Healthy Human Volunteers Placebo, SRT2104 - Healthy Volunteer, Atrophy, Muscular | Phase 1 | Withdrawn | | 2011-01-01 | 2015-04-17 |
A Clinical Trial to Assess the Safety of Oral SRT2104 and Its Effects on Vascular Dysfunction in Otherwise Healthy Cigarette Smokers and Subjects With Type 2 Diabetes Mellitus Placebo, SRT2104 - Diabetes Mellitus, Type 2 | Phase 1 | Completed | 38 | 2010-05-28 | 2017-06-20 |
Effect of SRT2104 on Endotoxin-induced Inflammation Placebo, SRT2104 - Sepsis | Phase 1 | Completed | 41 | 2009-12-09 | 2017-06-22 |
A Clinical Study to Assess the Safety, Tolerability and Pharmacokinetics of Oral SRT2104 Capsules Administered to Healthy Elderly Subjects for 28 Days Placebo, SRT2104 - Atrophy, Muscular | Phase 1 | Completed | 24 | 2009-10-01 | 2017-06-16 |
Clinical Study to Assess the Effects of SRT2104 and Prednisolone on Biomarkers in Blood in Healthy Volunteers Placebo, 0.25g SRT2104, Prednisolone - Pulmonary Disease, Chronic Obstructive | Phase 1 | Completed | 20 | 2009-04-06 | 2017-07-07 |
Clinical Study to Assess the Pharmacokinetics, Safety and Tolerability of SRT2104 Administered to Normal Healthy Male Volunteers SRT2104, Placebo - Diabetes Mellitus, Type 2 | Phase 1 | Completed | 10 | 2009-03-23 | 2017-07-07 |
A Clinical Study to Assess the Effect of Food and Gender on the Pharmacokinetics of SRT2104 Administered as an Oral Suspension or Capsule Formulation to Normal Healthy Volunteers 0.5g SRT2104 - Diabetes Mellitus, Type 2 | Phase 1 | Completed | 20 | 2009-01-20 | 2017-07-21 |
A Clinical Study to Assess the Safety and Pharmacokinetics of SRT2104 in Normal Healthy Male Volunteers SRT2104, Placebo - Diabetes Mellitus, Type 2, Healthy Volunteer | Phase 1 | Completed | 43 | 2008-05-01 | 2017-05-30 |
Conditions studied
Diabetes Mellitus, Type 2 (4) · Muscular Atrophy (2) · Colitis, Ulcerative (1) · Pulmonary Disease, Chronic Obstructive (1) · Sepsis (1)
Sponsors
GlaxoSmithKline (5) · Sirtris, a GSK Company (4)
Countries
United Kingdom (6) · Netherlands (1) · United States (1)
Results publications
PMID 23770971, PMID 25978169, PMID 26595549, PMID 27239324, PMID 28912956